{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:23:12Z","timestamp":1787682192739,"version":"build-2784847793"},"reference-count":107,"publisher":"Elsevier","isbn-type":[{"value":"9780323853019","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pmbts.2020.12.007","type":"book-chapter","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T13:54:52Z","timestamp":1611064492000},"page":"81-109","source":"Crossref","is-referenced-by-count":11,"title":["Advances in gene editing strategies for epidermolysis bullosa"],"prefix":"10.1016","author":[{"given":"Thomas","family":"Kocher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/bs.pmbts.2020.12.007_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdermsci.2014.02.005","article-title":"Genetic skin diseases related to desmosomes and corneodesmosomes","volume":"74","author":"Ishida-Yamamoto","year":"2014","journal-title":"J Dermatol Sci"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1684\/ejd.2011.1633","article-title":"Genetic skin diseases predisposing to basal cell carcinoma","volume":"22","author":"Castori","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/bs.ctm.2015.05.003","article-title":"Epidermal basement membrane in health and disease","volume":"76","author":"Has","year":"2015","journal-title":"Curr Top Membr"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.12.007_bb0025","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/jid.2009.108","article-title":"Phenotypic and genotypic analyses of genetic skin disease through the Online Mendelian Inheritance in Man (OMIM) database","volume":"129","author":"Feramisco","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.12.007_bb0030","first-page":"867","article-title":"Xeroderma pigmentosum: diagnostic procedures, interdisciplinary patient care, and novel therapeutic approaches","volume":"12","author":"Lehmann","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.12.007_bb0035","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.12.007_bb0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.18921","article-title":"Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility","volume":"183","author":"Has","year":"2020","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/bs.pmbts.2020.12.007_bb0045","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI38177","article-title":"Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility","volume":"119","author":"Coulombe","year":"2009","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2133.2000.03358.x","article-title":"The clinical spectrum of epidermolysis bullosa simplex","volume":"142","author":"Horn","year":"2000","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.12.007_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/21678707.2018.1463216","article-title":"Advances on potential therapeutic options for epidermolysis bullosa","volume":"6","author":"De Rosa","year":"2018","journal-title":"Expert Opin Orphan Drugs"},{"issue":"Suppl. 1","key":"10.1016\/bs.pmbts.2020.12.007_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10198-016-0783-4","article-title":"Social\/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe","volume":"17","author":"Angelis","year":"2016","journal-title":"Eur J Health Econ"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40291-020-00466-7","article-title":"Molecular therapeutics in development for epidermolysis bullosa: update 2020","volume":"24","author":"Has","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.12.007_bb0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejcb.2015.08.001","article-title":"Fibroblast heterogeneity and its implications for engineering organotypic skin models in vitro","volume":"94","author":"Sriram","year":"2015","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.12.007_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/exd.13141","article-title":"RNA-based therapies for genodermatoses","volume":"26","author":"Bornert","year":"2017","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/humu.20652","article-title":"The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases","volume":"29","author":"Szeverenyi","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.cb.11.110195.001011","article-title":"Keratins and the skin","volume":"11","author":"Fuchs","year":"1995","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"8","key":"10.1016\/bs.pmbts.2020.12.007_bb0090","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1073\/pnas.90.8.3197","article-title":"Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex","volume":"90","author":"Letai","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.12.007_bb0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1523-1747.1999.00495.x","article-title":"Identification of novel and known mutations in the genes for keratin 5 and 14 in Danish patients with epidermolysis bullosa simplex: correlation between genotype and phenotype","volume":"112","author":"Sorensen","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.12.007_bb0100","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/1523-1747.ep12491885","article-title":"Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14","volume":"97","author":"Ishida-Yamamoto","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.12.007_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00424265","article-title":"Abnormal organization of keratin intermediate filaments in cultured keratinocytes of epidermolysis bullosa simplex","volume":"281","author":"Kitajima","year":"1989","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jdermsci.2008.11.003","article-title":"Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition","volume":"53","author":"Chamcheu","year":"2009","journal-title":"J Dermatol Sci"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.12.007_bb0115","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1365-2133.2009.09615.x","article-title":"Epidermolysis bullosa simplex due to KRT5 mutations: mutation-related differences in cellular fragility and the protective effects of trimethylamine N-oxide in cultured primary keratinocytes","volume":"162","author":"Chamcheu","year":"2010","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/bs.pmbts.2020.12.007_bb0120","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/jid.2011.93","article-title":"Chemical chaperones protect epidermolysis bullosa simplex keratinocytes from heat stress-induced keratin aggregation: involvement of heat shock proteins and MAP kinases","volume":"131","author":"Chamcheu","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.omtm.2017.06.008","article-title":"Traceless targeting and isolation of gene-edited immortalized keratinocytes from epidermolysis bullosa simplex patients","volume":"6","author":"Aushev","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"8","key":"10.1016\/bs.pmbts.2020.12.007_bb0130","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jid.2019.03.1146","article-title":"Gene editing-mediated disruption of epidermolytic ichthyosis-associated KRT10 alleles restores filament stability in keratinocytes","volume":"139","author":"March","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.12.007_bb0135","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1172\/JCI119028","article-title":"A homozygous nonsense mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy","volume":"98","author":"Chavanas","year":"1996","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.12.007_bb0140","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ajhg.2016.11.005","article-title":"Monoallelic mutations in the translation initiation codon of KLHL24 cause skin fragility","volume":"99","author":"He","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/bs.pmbts.2020.12.007_bb0145","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/ng.3701","article-title":"Stabilizing mutations of KLHL24 ubiquitin ligase cause loss of keratin 14 and human skin fragility","volume":"48","author":"Lin","year":"2016","journal-title":"Nat Genet"},{"issue":"7680","key":"10.1016\/bs.pmbts.2020.12.007_bb0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.12.007_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjd.17075","article-title":"An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex","volume":"160","author":"Peking","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0160","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/ijms19030762","article-title":"RNA trans-splicing modulation via antisense molecule interference","volume":"19","author":"Liemberger","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/bs.pmbts.2020.12.007_bb0165","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1093\/hmg\/ddq405","article-title":"K14 mRNA reprogramming for dominant epidermolysis bullosa simplex","volume":"19","author":"Wally","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.12.007_bb0170","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.ymthe.2018.07.024","article-title":"CRISPR\/Cas9-mediated in situ correction of LAMB3 gene in keratinocytes derived from a junctional epidermolysis bullosa patient","volume":"26","author":"Benati","year":"2018","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.12.007_bb0175","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/mt.2013.290","article-title":"Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant","volume":"22","author":"Melo","year":"2014","journal-title":"Mol Ther"},{"issue":"9","key":"10.1016\/bs.pmbts.2020.12.007_bb0180","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/hum.1998.9.9-1359","article-title":"Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa","volume":"9","author":"Dellambra","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0185","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jid.2016.10.038","article-title":"Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells","volume":"137","author":"Bauer","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/bs.pmbts.2020.12.007_bb0190","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.12.007_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1535-7163.MCT-10-0669","article-title":"Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cells","volume":"10","author":"Gruber","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.12.007_bb0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/humu.21651","article-title":"The COL7A1 mutation database","volume":"33","author":"Wertheim-Tysarowska","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.me.44.020193.001201","article-title":"Epidermolysis bullosa","volume":"44","author":"Lin","year":"1993","journal-title":"Annu Rev Med"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.12.007_bb0210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/gt.2016.57","article-title":"Construction and validation of a RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations","volume":"23","author":"Tockner","year":"2016","journal-title":"Gene Ther"},{"issue":"7","key":"10.1016\/bs.pmbts.2020.12.007_bb0215","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/bs.pmbts.2020.12.007_bb0220","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"264","key":"10.1016\/bs.pmbts.2020.12.007_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009540","article-title":"Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa","volume":"6","author":"Sebastiano","year":"2014","journal-title":"Sci Transl Med"},{"issue":"17","key":"10.1016\/bs.pmbts.2020.12.007_bb0230","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/bs.pmbts.2020.12.007_bb0235","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/jid.2013.10","article-title":"Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa","volume":"133","author":"Woodley","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/bs.pmbts.2020.12.007_bb0240","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/jid.2015.158","article-title":"Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa","volume":"135","author":"Petrof","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.12.007_bb0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/cells9010112","article-title":"Context-dependent strategies for enhanced genome editing of genodermatoses","volume":"9","author":"March","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.12.007_bb0250","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1113\/EP086044","article-title":"Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders","volume":"103","author":"March","year":"2017","journal-title":"Exp Physiol"},{"issue":"8","key":"10.1016\/bs.pmbts.2020.12.007_bb0255","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/mt.2010.91","article-title":"SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa","volume":"18","author":"Titeux","year":"2010","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.12.007_bb0260","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.12.007_bb0265","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tibs.2015.08.006","article-title":"Microhomology-mediated end joining: a back-up survival mechanism or dedicated pathway?","volume":"40","author":"Sfeir","year":"2015","journal-title":"Trends Biochem Sci"},{"issue":"7\u20138","key":"10.1016\/bs.pmbts.2020.12.007_bb0270","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00335-017-9688-5","article-title":"Control of gene editing by manipulation of DNA repair mechanisms","volume":"28","author":"Danner","year":"2017","journal-title":"Mamm Genome"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.12.007_bb0275","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","article-title":"TALEN-based gene correction for epidermolysis bullosa","volume":"21","author":"Osborn","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0280","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.omtn.2019.09.011","article-title":"Improved double-nicking strategies for COL7A1 editing by homologous recombination","volume":"18","author":"Kocher","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.12.007_bb0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jcp.25053","article-title":"Error-prone repair of DNA double-strand breaks","volume":"231","author":"Rodgers","year":"2016","journal-title":"J Cell Physiol"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.12.007_bb0290","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.jid.2020.02.012","article-title":"Predictable CRISPR\/Cas9-mediated COL7A1 reframing for dystrophic epidermolysis bullosa","volume":"140","author":"Kocher","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.12.007_bb0295","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.molcel.2018.11.031","article-title":"Target-specific precision of CRISPR-mediated genome editing","volume":"73","author":"Chakrabarti","year":"2019","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.12.007_bb0300","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.12.007_bb0305","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.ymthe.2017.08.015","article-title":"Cut and paste: efficient homology-directed repair of a dominant negative KRT14 mutation via CRISPR\/Cas9 nickases","volume":"25","author":"Kocher","year":"2017","journal-title":"Mol Ther"},{"issue":"7785","key":"10.1016\/bs.pmbts.2020.12.007_bb0310","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"15","key":"10.1016\/bs.pmbts.2020.12.007_bb0315","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1073\/pnas.0800940105","article-title":"Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases","volume":"105","author":"Santiago","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0320","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.200810196","article-title":"Self-organization of keratin intermediate filaments into cross-linked networks","volume":"186","author":"Lee","year":"2009","journal-title":"J Cell Biol"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.12.007_bb0325","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1038\/jid.2009.131","article-title":"Recessive epidermolytic hyperkeratosis caused by a previously unreported termination codon mutation in the keratin 10 gene","volume":"129","author":"Terheyden","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"20","key":"10.1016\/bs.pmbts.2020.12.007_bb0330","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1073\/pnas.1512028113","article-title":"Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa","volume":"113","author":"Shinkuma","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/bs.pmbts.2020.12.007_bb0335","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jid.2019.02.015","article-title":"Efficient gene reframing therapy for recessive dystrophic epidermolysis bullosa with CRISPR\/Cas9","volume":"139","author":"Takashima","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.12.007_bb0340","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.2010.09713.x","article-title":"The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation","volume":"163","author":"Escamez","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.19","article-title":"Gene editing for the efficient correction of a recurrent COL7A1 mutation in recessive dystrophic epidermolysis bullosa keratinocytes","volume":"5","author":"Chamorro","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"10.1016\/bs.pmbts.2020.12.007_bb0350","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.1614775114","article-title":"Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model","volume":"114","author":"Wu","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0355","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.omtn.2018.01.009","article-title":"Deletion of a pathogenic mutation-containing exon of COL7A1 allows clonal gene editing correction of RDEB patient epidermal stem cells","volume":"11","author":"Mencia","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.12.007_bb0360","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","article-title":"Clinically relevant correction of recessive dystrophic epidermolysis bullosa by dual sgRNA CRISPR\/Cas9-mediated gene editing","volume":"27","author":"Bonafont","year":"2019","journal-title":"Mol Ther"},{"issue":"26","key":"10.1016\/bs.pmbts.2020.12.007_bb0365","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1074\/jbc.M709452200","article-title":"Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis","volume":"283","author":"Woodley","year":"2008","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/bs.pmbts.2020.12.007_bb0370","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/sj.jid.5700435","article-title":"Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients","volume":"126","author":"Goto","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/bs.pmbts.2020.12.007_bb0375","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2016.07.029","article-title":"Targeted exon skipping restores type VII collagen expression and anchoring fibril formation in an in vivo RDEB model","volume":"136","author":"Turczynski","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.12.007_bb0380","article-title":"Antisense oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa","volume":"5","author":"Bremer","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0385","article-title":"QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study","author":"Bornert","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"7733","key":"10.1016\/bs.pmbts.2020.12.007_bb0390","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-018-0686-x","article-title":"Predictable and precise template-free CRISPR editing of pathogenic variants","volume":"563","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.colsurfb.2017.07.051","article-title":"Advances and challenges in stem cell culture","volume":"159","author":"McKee","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0400","first-page":"16014","article-title":"CRISPR\/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa","volume":"1","author":"Webber","year":"2016","journal-title":"Regen Med"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.12.007_bb0405","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jid.2015.11.028","article-title":"Meganuclease-mediated COL7A1 gene correction for recessive dystrophic epidermolysis bullosa","volume":"136","author":"Izmiryan","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0410","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.omtn.2018.06.008","article-title":"Ex vivo COL7A1 correction for recessive dystrophic epidermolysis bullosa using CRISPR\/Cas9 and homology-directed repair","volume":"12","author":"Izmiryan","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.12.007_bb0415","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ymthe.2017.07.005","article-title":"COL7A1 editing via CRISPR\/Cas9 in recessive dystrophic epidermolysis bullosa","volume":"25","author":"Hainzl","year":"2017","journal-title":"Mol Ther"},{"issue":"52","key":"10.1016\/bs.pmbts.2020.12.007_bb0420","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1073\/pnas.1907081116","article-title":"CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells","volume":"116","author":"Jackow","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0425","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jdermsci.2020.04.004","article-title":"Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR\/Cas9 and piggyBac transposon system","volume":"98","author":"Itoh","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/bs.pmbts.2020.12.007_bb0430","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/mt.2013.143","article-title":"Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination","volume":"21","author":"Coluccio","year":"2013","journal-title":"Mol Ther"},{"issue":"5\u20136","key":"10.1016\/bs.pmbts.2020.12.007_bb0435","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drudis.2010.01.006","article-title":"Homologous recombination in human iPS and ES cells for use in gene correction therapy","volume":"15","author":"Nakayama","year":"2010","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.12.007_bb0440","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jid.2019.07.701","article-title":"Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs","volume":"140","author":"Osborn","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"21","key":"10.1016\/bs.pmbts.2020.12.007_bb0445","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1073\/pnas.1100332108","article-title":"Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells","volume":"108","author":"Itoh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.12.007_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077673","article-title":"Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs)","volume":"8","author":"Itoh","year":"2013","journal-title":"PLoS One"},{"issue":"264","key":"10.1016\/bs.pmbts.2020.12.007_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010083","article-title":"Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa","volume":"6","author":"Wenzel","year":"2014","journal-title":"Sci Transl Med"},{"issue":"9\u201310","key":"10.1016\/bs.pmbts.2020.12.007_bb0460","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/0963689719857657","article-title":"Collagen VII expression is required in both keratinocytes and fibroblasts for anchoring fibril formation in bilayer engineered skin substitutes","volume":"28","author":"Supp","year":"2019","journal-title":"Cell Transplant"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.12.007_bb0465","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/ijms19040946","article-title":"CRISPR\/Cas9-based cellular engineering for targeted gene overexpression","volume":"19","author":"Osborn","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/bs.pmbts.2020.12.007_bb0470","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"7603","key":"10.1016\/bs.pmbts.2020.12.007_bb0475","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"7681","key":"10.1016\/bs.pmbts.2020.12.007_bb0480","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/bs.pmbts.2020.12.007_bb0485","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/bs.pmbts.2020.12.007_bb0490","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"Suppl. 1","key":"10.1016\/bs.pmbts.2020.12.007_bb0495","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/scrt363","article-title":"Building a microphysiological skin model from induced pluripotent stem cells","volume":"4","author":"Guo","year":"2013","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.12.007_bb0500","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.12.007_bb0505","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth.4278","article-title":"CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets","volume":"14","author":"Tsai","year":"2017","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.12.007_bb0510","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nbt.3101","article-title":"Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases","volume":"33","author":"Frock","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.12.007_bb0515","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/mt.2015.54","article-title":"Genome editing technologies: defining a path to clinic","volume":"23","author":"Corrigan-Curay","year":"2015","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.12.007_bb0520","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nbt.4066","article-title":"A highly specific SpCas9 variant is identified by in vivo screening in yeast","volume":"36","author":"Casini","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"7676","key":"10.1016\/bs.pmbts.2020.12.007_bb0525","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR-Cas9 targeting accuracy","volume":"550","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.pmbts.2020.12.007_bb0530","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat Med"},{"issue":"6096","key":"10.1016\/bs.pmbts.2020.12.007_bb0535","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.12.007_bb0540","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMra1800729","article-title":"A new class of medicines through DNA editing","volume":"380","author":"Porteus","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Progress in Molecular Biology and Translational Science","Curing Genetic Diseases Through Genome Reprogramming"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117320301770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117320301770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T19:47:15Z","timestamp":1681760835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117320301770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780323853019"],"references-count":107,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2020.12.007","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}